The detection rates of mutations of <i>KRAS</i>, <i>TP53</i>, <i>CDKN2A</i>, and <i>SMAD4</i>.
Tetsuya Ishizawa
Naohiko Makino
Akiko Matsuda
Yasuharu Kakizaki
Toshikazu Kobayashi
Chisaki Ikeda
Shinpei Sugahara
Michihiko Tsunoda
Yoshiyuki Ueno
10.1371/journal.pone.0228565.g002
https://plos.figshare.com/articles/figure/The_detection_rates_of_mutations_of_i_KRAS_i_i_TP53_i_i_CDKN2A_i_and_i_SMAD4_i_/11772753
<p>The detection rates of mutations of <i>KRAS</i>, <i>TP53</i>, <i>CDKN2A</i>, and <i>SMAD4</i>.</p>
2020-01-30 18:40:08
KRAS mutation analysis
retrospective study Pancreatic cancer
2A
2017. DNA sequences
cancer gene panel testing
SMAD
CDKN
endoscopic ultrasound-guided fine-needle aspiration
polymerase chain reaction
NGS
ROSE specimens
unresectable PC patients
5- year survival rate
KRAS mutations
TP
Ion AmpliSeq Comprehensive Caner Panel